Re: Recommendation from my 2nd opinion...
"Does anyone know when this TDM1 trail will be get past FDA?"
Roche is on record to present in Dec at SABCS results from a 3rd line MBC TDM1 phaseII trial and based on positive outcome from this evaluation to request FDA approval for this setting in 2010.
|